Hope for ALS sufferers
available to them until new drugs are approved.
For many who measure their lifetimes in months,
that’s just not good enough.
Treatment Access for TODAY’S ALS Patients
We don’t just WANT earlier treatment access.
We are leading the work to make it a reality
for patients who cannot wait.
We bring the funding and the in-house expertise required to
conduct expanded access treatment programs (EAP),
in partnership with commercial drug sponsors and ALS clinics.
The Result: Earlier treatment options for more ALS patients.